XTLB Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own XTLB shares is 4, representing 1.92% of the company's common stock.

CENTRAL TRUST CO, in the last quarter, reduced its stake in XTLB by -100% restricting it's holding to 0 shares of worth nearly -. MORGAN STANLEY also lessened -1.51% of the XTLB shares from its portfolio, reducing its holding to 39.17 thousand shares of worth $110.07K. MORGAN STANLEY also shunned XTLB shares holding by -1.97% last quarter which brought its holding to 39.77 thousand shares worth $40.17K.

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in XTLB by 100% in the last quarter. The institutional holder raised its holding to 13.63 thousand shares having worth more than $38.30K. UBS GROUP AG also added 12,777.78% more shares of XTLB to its portfolio, raising its holding to 6.95 thousand shares of worth $19.54K. CENTRAL TRUST CO also increased its XTLB shares holding by 100% which brought its holding to 200 shares worth $203.00K.

The insider with the most stakes in XTLB is EDELMAN JOSEPH , 10 percent owner at the company. Additionally, XTLB stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 5.3% percent of XTL Biopharmaceuticals Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which XTLB insiders have sold stock, totaling 0 shares. Insiders that have sold shares include EDELMAN JOSEPH.

There have been 0 transaction(s) during the past 6-months in which XTL Biopharmaceuticals Ltd. insiders have bought stock, totalling 0 shares

Around 0 XTL Biopharmaceuticals Ltd. shares are held by insiders, which represents about 5.3% of XTLB stock.

XTLB 10 percent owner, EDELMAN JOSEPH holds the largest portfolio of the company's shares. XTLB shares owned by EDELMAN total nearly 20.58 million.

CENTRAL TRUST CO is the largest institutional owner in XTLB which holds 0 shares worth - or 0% of the total XTLB shares outstanding followed by NOKED ISRAEL LTD with ownership of 198.89 thousand shares representing 3.65% of the XTLB ownership. MORGAN STANLEY is the third largest stakeholder with 39.17 thousand shares or 0.72% of the ownership worth more than $110.07K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the XTLB is concerned, it is a stock which is not optionable.

Number of XTLB shares short is 1.79K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 5.45M shares of XTLB are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, XTLB has 413.26M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for XTLB is null.